Delivery Order SPE2DR25D9988-SPE2DR26FCEV2
Award Date 4/13/26
Potential Completion Date 4/14/26
Potential Value $3.1K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 13, 2026, for Procainamide 1 gram/10 mL vials, with a ceiling value of $3,132.00. This delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price calls for pharmaceutical products and medical consumables to support Department of Defense healthcare operations. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 8, 2026, for $3,132.00 (ceiling value) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency-administered indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations globally. The order procures Procainamide 1 gram per 10 milliliter vials. Place of performance is Park Ridge,...
- The Defense Logistics Agency's Medical Supply Chain division issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical and medical consumable supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 3, 2026, for procainamide 1 gram/10 mL vials. The order was issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler based...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on April 1, 2026, for Procainamide 1 gram/10 mL vial (10 mL), with an ultimate completion date of April 2, 2026. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $499.999 billion single-award IDC with a ceiling value of $499,999,999 and completion through December 31, 2036. The program...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 8, 2026, for procainamide 1 gram/10 mL vials. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract with a $499.9 billion ceiling that authorizes firm fixed-price calls for pharmaceutical products and medical consumables supporting...
- The Defense Logistics Agency's Medical Supply Chain issued a $1,605.15 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for procainamide 1 gram/10 mL vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. PPV-G GEN V is the Defense Logistics Agency's $30.3 billion pharmaceutical prime vendor acquisition strategy authorizing issuance of firm fixed-price delivery orders for branded and generic prescription drugs,...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on April 6, 2026, for procainamide 1 gram/10 ml vial with a ceiling value of $6,123.08, issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical...
- The Defense Logistics Agency issued a $1,530.77 delivery order to DMS Pharmaceutical Group Inc. on April 7, 2026, for procainamide 1 gram per 10 milliliter vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support military...